2019-nCoV RT-qPCR Detection Kit is intended for the detection of 2019-Novel Coronavirus (2019-nCoV, SARS-Cov2). The detection result of this product is only for clinical reference, and it should not be used as the only evidence for clinical diagnosis and treatment for COVID-19.
Highly conserved region containing ORF1ab and N gene in the novel coronavirus (SARS-CoV-2) genome is used to design specific primers and probes in this kit. Based on the fluorescence quantitative PCR platform, the principle of one-step fluorescence quantitative reverse transcription PCR was used to qualitatively detect the new coronavirus (SARS-CoV-2). PCR detection system uses Human Actin to design primers and probes as internal control, which can monitor the quality of respiratory nucleic acid and whole PCR reaction system. It avoids the risk of blank samples and false negatives.
|Component:||1. Detection Buffer: 950 µl|
2. Enzyme Mix: 50 µl
3. Positive Control: 200 µl
4. Negative Control: 200 µl
|Storage:||All reagents should be stored at -30°C~-15°C with protection from light.|
LifeSct LLC is a high-tech biotech corporation, focusing on genomic and proteomic technology. LifeSct utilizes scientific excellence, a commitment to customer service and unsurpassed product quality to help our clients realize their research goals in the rapidly evolving world of genomics and proteomics.